AZD-1705

N/A

Report date: 2024/03/11 17:41:31
NME

Base Information

Drug NameAZD-1705
Drug Alias NameAZD1705AZD-1705
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiopoietin like 3 modulators
TargetsAngiopoietin like 3
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesParexel International CorpAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesParexel International CorpAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A